Perkins Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-9,520
| Closed | -$483K | – | 115 |
|
2017
Q3 | $483K | Hold |
9,520
| – | – | 0.51% | 60 |
|
2017
Q2 | $513K | Sell |
9,520
-960
| -9% | -$51.7K | 0.57% | 55 |
|
2017
Q1 | $552K | Sell |
10,480
-1,600
| -13% | -$84.3K | 0.57% | 60 |
|
2016
Q4 | $582K | Sell |
12,080
-800
| -6% | -$38.5K | 0.64% | 56 |
|
2016
Q3 | $694K | Buy |
12,880
+1,960
| +18% | +$106K | 0.69% | 49 |
|
2016
Q2 | $592K | Sell |
10,920
-840
| -7% | -$45.5K | 0.68% | 50 |
|
2016
Q1 | $596K | Sell |
11,760
-840
| -7% | -$42.6K | 0.75% | 51 |
|
2015
Q4 | $636K | Buy |
12,600
+1,000
| +9% | +$50.5K | 0.68% | 50 |
|
2015
Q3 | $558K | Buy |
11,600
+880
| +8% | +$42.3K | 0.62% | 56 |
|
2015
Q2 | $558K | Sell |
10,720
-80
| -0.7% | -$4.16K | 0.49% | 67 |
|
2015
Q1 | $623K | Hold |
10,800
| – | – | 0.52% | 68 |
|
2014
Q4 | $577K | Buy |
10,800
+200
| +2% | +$10.7K | 0.5% | 74 |
|
2014
Q3 | $609K | Hold |
10,600
| – | – | 0.51% | 69 |
|
2014
Q2 | $709K | Sell |
10,600
-280
| -3% | -$18.7K | 0.5% | 67 |
|
2014
Q1 | $727K | Sell |
10,880
-1,360
| -11% | -$90.9K | 0.51% | 69 |
|
2013
Q4 | $817K | Hold |
12,240
| – | – | 0.55% | 67 |
|
2013
Q3 | $768K | Sell |
12,240
-800
| -6% | -$50.2K | 0.55% | 66 |
|
2013
Q2 | $815K | Buy |
+13,040
| New | +$815K | 0.65% | 58 |
|